Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis

Abstract Prokineticin 2 (PK2) is a secreted protein involved in several pathological and physiological processes, including the regulation of inflammation, sickness behaviors, and circadian rhythms. Recently, it was reported that PK2 is associated with the pathogenesis of collagen-induced arthritis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kentaro Noda, Bianca Dufner, Haruyasu Ito, Ken Yoshida, Gianfranco Balboni, Rainer H. Straub
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1feb67cc248e45599d30593e9f2beb41
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1feb67cc248e45599d30593e9f2beb41
record_format dspace
spelling oai:doaj.org-article:1feb67cc248e45599d30593e9f2beb412021-12-02T18:02:14ZDifferential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis10.1038/s41598-021-97809-z2045-2322https://doaj.org/article/1feb67cc248e45599d30593e9f2beb412021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97809-zhttps://doaj.org/toc/2045-2322Abstract Prokineticin 2 (PK2) is a secreted protein involved in several pathological and physiological processes, including the regulation of inflammation, sickness behaviors, and circadian rhythms. Recently, it was reported that PK2 is associated with the pathogenesis of collagen-induced arthritis in mice. However, the role of PK2 in the pathogenesis of rheumatoid arthritis (RA) or osteoarthritis (OA) remains unknown. In this study, we collected synovial tissue, plasma, synovial fluid, and synovial fibroblasts (SF) from RA and OA patients to analyze the function of PK2 using immunohistochemistry, enzyme-linked immunosorbent assays, and tissue superfusion studies. PK2 and its receptors prokineticin receptor (PKR) 1 and 2 were expressed in RA and OA synovial tissues. PKR1 expression was downregulated in RA synovial tissue compared with OA synovial tissue. The PK2 concentration was higher in RA synovial fluid than in OA synovial fluid but similar between RA and OA plasma. PK2 suppressed the production of IL-6 from TNFα-prestimulated OA-SF, and this effect was attenuated in TNFα-prestimulated RA-SF. This phenomenon was accompanied by the upregulation of PKR1 in OA-SF. This study provides a new model to explain some aspects underlying the chronicity of inflammation in RA.Kentaro NodaBianca DufnerHaruyasu ItoKen YoshidaGianfranco BalboniRainer H. StraubNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kentaro Noda
Bianca Dufner
Haruyasu Ito
Ken Yoshida
Gianfranco Balboni
Rainer H. Straub
Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis
description Abstract Prokineticin 2 (PK2) is a secreted protein involved in several pathological and physiological processes, including the regulation of inflammation, sickness behaviors, and circadian rhythms. Recently, it was reported that PK2 is associated with the pathogenesis of collagen-induced arthritis in mice. However, the role of PK2 in the pathogenesis of rheumatoid arthritis (RA) or osteoarthritis (OA) remains unknown. In this study, we collected synovial tissue, plasma, synovial fluid, and synovial fibroblasts (SF) from RA and OA patients to analyze the function of PK2 using immunohistochemistry, enzyme-linked immunosorbent assays, and tissue superfusion studies. PK2 and its receptors prokineticin receptor (PKR) 1 and 2 were expressed in RA and OA synovial tissues. PKR1 expression was downregulated in RA synovial tissue compared with OA synovial tissue. The PK2 concentration was higher in RA synovial fluid than in OA synovial fluid but similar between RA and OA plasma. PK2 suppressed the production of IL-6 from TNFα-prestimulated OA-SF, and this effect was attenuated in TNFα-prestimulated RA-SF. This phenomenon was accompanied by the upregulation of PKR1 in OA-SF. This study provides a new model to explain some aspects underlying the chronicity of inflammation in RA.
format article
author Kentaro Noda
Bianca Dufner
Haruyasu Ito
Ken Yoshida
Gianfranco Balboni
Rainer H. Straub
author_facet Kentaro Noda
Bianca Dufner
Haruyasu Ito
Ken Yoshida
Gianfranco Balboni
Rainer H. Straub
author_sort Kentaro Noda
title Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis
title_short Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis
title_full Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis
title_fullStr Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis
title_full_unstemmed Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis
title_sort differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1feb67cc248e45599d30593e9f2beb41
work_keys_str_mv AT kentaronoda differentialinflammationmediatedfunctionofprokineticin2inthesynovialfibroblastsofpatientswithrheumatoidarthritiscomparedwithosteoarthritis
AT biancadufner differentialinflammationmediatedfunctionofprokineticin2inthesynovialfibroblastsofpatientswithrheumatoidarthritiscomparedwithosteoarthritis
AT haruyasuito differentialinflammationmediatedfunctionofprokineticin2inthesynovialfibroblastsofpatientswithrheumatoidarthritiscomparedwithosteoarthritis
AT kenyoshida differentialinflammationmediatedfunctionofprokineticin2inthesynovialfibroblastsofpatientswithrheumatoidarthritiscomparedwithosteoarthritis
AT gianfrancobalboni differentialinflammationmediatedfunctionofprokineticin2inthesynovialfibroblastsofpatientswithrheumatoidarthritiscomparedwithosteoarthritis
AT rainerhstraub differentialinflammationmediatedfunctionofprokineticin2inthesynovialfibroblastsofpatientswithrheumatoidarthritiscomparedwithosteoarthritis
_version_ 1718378914088222720